我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
42
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1893
进行中(未招募)
1
2.4%
已完成
30
71.4%
尚未招募
2
4.8%
招募中
7
16.7%
Unknown
暂无批准数据
- Montana State University scientists discovered a previously unknown backup system that allows mammalian cells to produce the essential amino acid cysteine when primary disulfide reductase systems fail. - The nine-year study, published in Nature Chemical Biology, overturns the long-held belief that cells cannot survive without functioning disulfide reductase systems. - The newly identified pathway chemically severs a carbon-sulfur bond in cystine to release cysteine, a mechanism that may have evolved to protect against electrophilic toxins. - Researchers suggest this same protective pathway may shield cancer cells from chemotherapy, radiation, and immunotherapy, and disabling it could enhance treatment susceptibility.